Silenor FDA Approval History
FDA Approved: Yes (First approved March 17, 2010)
Brand name: Silenor
Generic name: doxepin
Dosage form: Tablets
Company: Somaxon Pharmaceuticals, Inc.
Treatment for: Insomnia
Silenor (doxepin) is a low-dose oral tablet formulation of the H1 receptor antagonist doxepin indicated for the treatment of insomnia characterized by difficulties with sleep maintenance.
Development timeline for Silenor
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.